Helen Louise Collins's Net Worth

$6.41 Million

Estimate Recalculated Nov 1, 2024 11:31AM EST

Who is Helen Louise Collins

Helen Louise Collins has an estimated net worth of $6.41 Million. This is based on reported shares across multiple companies, which include Kura Oncology, Inc., Enliven Therapeutics, Inc., FIVE PRIME THERAPEUTICS, INC., and IO Biotech, Inc..

SEC CIK

Helen Louise Collins's CIK is 0001701247

Past Insider Trading and Trends

2020 was Helen Louise Collins's most active year for acquiring shares with 6 total transactions. Helen Louise Collins's most active month to acquire stocks was the month of January. 2021 was Helen Louise Collins's most active year for disposing of shares, totalling 11 transactions. Helen Louise Collins's most active month to dispose stocks was the month of January. 2024 saw Helen Louise Collins paying a total of $49,600.00 for 276,642 shares, this is the most they've acquired in one year. In 2021 Helen Louise Collins cashed out on 519,534 shares for a total of $5,345,569.19, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Kura Oncology, Inc.

Investor
Updated Jun 07, 2024
26.00KJun 05
26.00KMay 31
23.00KJun 21
65.17KJul 28
Showing 5 results

Enliven Therapeutics, Inc.

CHIEF MEDICAL OFFICER
Updated Oct 22, 2024
266.27KScheduledOct 18
267.08KScheduledApr 11
185.00KFeb 13
206.00KApr 04
287.08KFeb 23
Showing 6 results

FIVE PRIME THERAPEUTICS, INC.

EVP and Chief Medical Officer
Updated Apr 19, 2021
Mar 31 - Apr 16
Feb 26
Feb 24 - Feb 25
Dec 11
Nov 11
Aug 20
Mar 20
Feb 24 - Feb 26
Feb 05
Sep 01
64.79KAug 20
44.00KJun 24
Form 3/A
Feb 25 - Feb 26
Feb 05
Sep 28
Sep 01
Jun 23
Mar 20
Jun 23 - Feb 26
Form 3/A25.16K
Feb 05
Sep 01
25.16KApr 24
115.41KMar 20
20.16K
Showing 26 results

IO Biotech, Inc.

Investor
Updated Jun 07, 2024
45.64KJun 06
64.24KNov 15
Showing 3 results